SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Teetime who wrote (31315)7/8/2015 1:57:48 PM
From: allatwwk  Read Replies (1) of 63324
 
teetime

I do buy into the theory that all the IMMU share movement is basically just noise ahead of UCB and whatever the data will show. At least for me it is, since at these levels, I do not intend to add or sell shares.

The lack of confidence (as reflected in the share price) being shown in a company with a significant chance to become one of the major financial beneficiaries in dealing with a difficult and widespread disease -- that really is shocking to me. Even with the discount IMMU merits due to its mgmt team.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News